ASILX
Price
$16.38
Change
+$0.01 (+0.06%)
Updated
Dec 3 closing price
Net Assets
1.56B
NLSCX
Price
$18.83
Change
-$0.02 (-0.11%)
Updated
Dec 3 closing price
Net Assets
7.99B
Interact to see
Advertisement

ASILX vs NLSCX

Header iconASILX vs NLSCX Comparison
Open Charts ASILX vs NLSCXBanner chart's image
AB Select US Long/Short I
Price$16.38
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets1.56B
Neuberger Berman Long Short C
Price$18.83
Change-$0.02 (-0.11%)
VolumeN/A
Net Assets7.99B
ASILX vs NLSCX Comparison Chart in %
View a ticker or compare two or three
VS
ASILX vs. NLSCX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASILX is a Buy and NLSCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NLSCX has more cash in the bank: 8B vs. ASILX (1.56B). ASILX pays higher dividends than NLSCX: ASILX (0.66) vs NLSCX (0.00). ASILX was incepted earlier than NLSCX: ASILX (13 years) vs NLSCX (14 years). NLSCX (2.43) is less costly to investors than ASILX (1.71). ASILX is a more actively managed with annual turnover of: 296.00 vs. NLSCX (48.00). NLSCX has a lower initial minimum investment than ASILX: NLSCX (1000) vs ASILX (2000000). NLSCX annual gain was more profitable for investors over the last year : 6.13 vs. ASILX (0.76). ASILX return over 5 years is better than : 17.71 vs. NLSCX (15.78).
ASILXNLSCXASILX / NLSCX
Total Expense Ratio1.672.4369%
Annual Report Gross Expense Ratio1.712.4370%
Fund Existence13 years14 years-
Gain YTD9.3656.614142%
Front LoadN/AN/A-
Min. Initial Investment20000001000200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B8B20%
Annual Yield % from dividends0.660.00-
Returns for 1 year0.766.1312%
Returns for 3 years23.8117.00140%
Returns for 5 years17.7115.78112%
Returns for 10 years40.2445.2289%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NWPHF9.36N/A
N/A
Newron Pharmaceuticals SPA
EQTL1.25N/A
N/A
Equitech Int'l Corp.
MBGPF0.92N/A
N/A
MOBERG PHARMA AB
ANIOY6.94N/A
N/A
Acerinox S.A.
ASCCF23.60N/A
N/A
Asics Corp.